OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lipoxin-mediated signaling: ALX/FPR2 interaction and beyond
Sergio Sánchez‐García, Rafael I. Jaén, María Fernández‐Velasco, et al.
Pharmacological Research (2023) Vol. 197, pp. 106982-106982
Open Access | Times Cited: 13

Showing 13 citing articles:

Specialized pro-resolving lipid mediators in gut immunophysiology: from dietary precursors to inflammation resolution
Emmanuel Albuquerque‐Souza, Jesmond Dalli
Current Opinion in Clinical Nutrition & Metabolic Care (2025)
Closed Access | Times Cited: 1

The Role of Endogenous Specialized Proresolving Mediators in Mast Cells and Their Involvement in Inflammation and Resolution
Nobuyuki Fukuishi, K. Takahama, Hiromasa Kurosaki, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1491-1491
Open Access | Times Cited: 1

Pro-resolving metabolites: Future of the fish oil supplements
Asma Maliha, Maisha Tahsin, Tayeba Zaman Fabia, et al.
Journal of Functional Foods (2024) Vol. 121, pp. 106439-106439
Open Access | Times Cited: 6

Lipoxin A4 levels correlate with severity in a Spanish COVID-19 cohort: potential use of endogenous pro-resolving mediators as biomarkers
Sergio Sánchez‐García, Rafael I. Jaén, Roberto Lozano‐Rodríguez, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access

Exploring receptors for pro-resolving and non-pro-resolving mediators as therapeutic targets for sarcopenia
Tiantian Wang, Sihan Chen, Dongmei Zhou, et al.
Metabolism (2025), pp. 156148-156148
Closed Access

Lipid metabolism and therapy: another year of exciting advances
Dan Linetzky Waitzberg, Philip C. Calder
Current Opinion in Clinical Nutrition & Metabolic Care (2025) Vol. 28, Iss. 2, pp. 51-53
Closed Access

LXA4 alleviates inflammation and ferroptosis in cigarette smoke induced chronic obstructive pulmonary disease via the ALX/FPR2 receptor
Xin Li, Hui Xu, Kai Liu, et al.
International Immunopharmacology (2025) Vol. 151, pp. 114322-114322
Closed Access

Lipoxin A4/FPR2 Signaling Mitigates Ferroptosis of Alveolar Epithelial Cells via NRF2‐Dependent Pathway During Lung Ischemia–Reperfusion Injury
Denny Joseph Manual Kollareth, Victoria Leroy, Zhenxiao Tu, et al.
The FASEB Journal (2025) Vol. 39, Iss. 8
Closed Access

Annexin A1 improves immune responses and control of tissue parasitism during Leishmania amazonensis infection in BALB/c mice
Tiago Queiroga Nery Ricotta, Liliane Martins dos Santos, Laser Antônio Machado Oliveira, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 172, pp. 116254-116254
Open Access | Times Cited: 1

Lipoxin A4/FPR2 signaling mitigates ferroptosis of alveolar epithelial cells via NRF2-dependent pathway during lung ischemia-reperfusion injury
Denny Joseph Manual Kollareth, Victoria Leroy, Zhenxiao Tu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1

Lipoxin A4 suppresses neutrophil extracellular traps formation through the FPR2-dependent regulation of METTL3 in ischemic stroke
Na Wei, Lu Tan, Jifeng Gu, et al.
Brain Research Bulletin (2024), pp. 111178-111178
Open Access | Times Cited: 1

Failure to Resolve Inflammation Contributes to Juvenile-Onset Cardiomyopathy in a Mouse Model of Duchenne Muscular Dystrophy
James S. Novak, Amy Lischin, Prech Uapinyoying, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Page 1

Scroll to top